严重放射性淋巴细胞减少的食管癌患者放化疗后淋巴细胞恢复与预后的关系
该研究回顾755例I-III期食管癌患者,接受同步放化疗(±手术),期间294例(38.9%)出现G4淋巴细胞减少;至首次随访406例(53.8%)恢复至Gr0-1。多变量分析显示G4淋巴细胞减少独立预测更差总生存,但淋巴细胞恢复与更好预后无关;G4且恢复者5年OS仍低于G0-3且未恢复者(36.6% vs 51.9%,HR=1.40,95%CI 1.04-1.89,P=0.027)。
要点
- 同步放化疗期间G4淋巴细胞减少发生率为38.9%(294/755),为独立不良预后因素。
- 放化疗后淋巴细胞恢复(Gr0-1)与更好预后无关。
- G4且恢复者5年OS仍低于G0-3且未恢复者(36.6% vs 51.9%,HR=1.40,P=0.027)。
核心结论
- 放化疗后淋巴细胞计数恢复不能改变治疗期间高级别淋巴细胞减少带来的不良长期结局。
研究设计与样本
- 回顾性分析2004-2015年755例接受同步放化疗(伴或不伴手术)的I-III期食管癌患者,于放化疗前、中及首次随访时行全血细胞计数,淋巴细胞减少按CTCAE v4.03分级,采用单变量和多变量Cox比例风险回归分析临床因素与淋巴细胞减少分级和生存的关系。
主要发现
- 同步放化疗期间294例(38.9%)出现G4淋巴细胞减少;至首次随访406例(53.8%)恢复至Gr0-1。
- 多变量分析中,相对于同步放化疗期间G0-3淋巴细胞减少患者,G4淋巴细胞减少独立预测更差总生存。
- 淋巴细胞恢复与更好预后无关;同步放化疗期间G4且之后恢复(Gr0-1)者5年OS率仍低于期间G0-3且之后未恢复(Gr2-4)者(36.6% vs 51.9%,HR=1.40,95%CI 1.04-1.89,P=0.027)。
- 淋巴细胞恢复能力(放化疗后ALC除以放化疗前ALC)不受同步放化疗期间淋巴细胞减少分级影响(G0-3为0.66 vs G4为0.65,P=0.473)。
- 在治疗期间G4淋巴细胞减少患者中,淋巴细胞恢复仅与放化疗前淋巴细胞计数相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Radiation-induced lymphopenia (RIL) during therapy is associated with poor prognosis but is often temporary and resolves after treatment completion in esophageal cancer. How lymphocyte recovery contributes to prognosis is unknown. METHODS: We reviewed 755 patients with stage I-III esophageal carcinoma who received concurrent chemoradiation therapy (CRT) with or without surgery in 2004-2015. Complete blood counts were obtained before, during, and at first follow-up after CRT. Lymphopenia was graded per the Common Terminology Criteria for Adverse Events v4.03 during CRT (G) and as recovery after CRT (Gr). Clinical factors and lymphopenia grade were tested for association with survival in univariable and multivariable Cox proportional hazard regression analyses. RESULTS: During CRT, 294 patients (38.9%) had G4 lymphopenia; by the first follow-up, 406 patients (53.8%) had recovered (Gr0-1). Relative to patients with G0-3 lymphopenia during CRT, G4 lymphopenia independently predicted worse OS in multivariable analyses. However, lymphocyte recovery was not associated with a better prognosis. Patients with G4 lymphopenia during CRT and recovery (Gr0-1) afterward still had poorer 5-year OS rate than patients with G0-3 during CRT without recovery (Gr2-4) afterward (36.6% vs. 51.9%, HR = 1.40, 95% CI 1.04-1.89, P = 0.027). Moreover, the lymphocyte recovery ability (post-CRT ALC divided by pre-CRT ALC) was not affected by lymphopenia grade during CRT (0.66 in G0-3 vs. 0.65 in G4, p = 0.473). Among patients with G4 lymphopenia during treatment, lymphocyte recovery was only associated with pre-CRT lymphocyte counts. CONCLUSION: Lymphocyte count recovery after CRT does not alter the poor long-term outcomes brought about by high-grade lymphopenia during CRT.
引用
- Deng W, Xu C, Liu A, et al. The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy. Radiother Oncol. 2019. PMID: 30935587. doi:10.1016/j.radonc.2018.12.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。